Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel Parasternal Block in Cardiac Surgery
NCT01826851Phase 2Completed
- Start
- Mar 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Exparel with Placebo (2 arms). Primary endpoints: Median Cumulative Morphine Equivalent at 72 hours and Median Pain Levels at 72 hours. Started Mar 2013; status: completed.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01826851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01826851.